ALX-0651
Product Specifications
Target
CXCR
Related Pathways
Autophagy, Immunology/Inflammation, GPCR/G Protein
Bioactivity
ALX-0651 is a dual-complementarity-determining region humanized monoclonal antibody inhibitor targeting CXCR4. It can inhibit the transport of hematopoietic stem cells as well as the progression and metastasis of tumors. ALX-0651 is applicable for research in treating non-Hodgkin's lymphoma and multiple myeloma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog